Back

Evaluation of risk/benefit in lead extraction of noninfected leads?

8 April 2024 (11:15 - 11:30)
Organised by: Logo
Congress Presentation Part of: Noninfected lead extraction indications: what should I consider! Device Complications and Lead Extraction EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Laszlo Alajos Geller

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

3 More presentations in this session

Presentation thumbnail
Tricuspid valve adhesions: what to do during LE in noninfective indications?
Professor F. Migliore (Padova, IT)
Slides
Presentation thumbnail
Collateral lead damage when extracting noninfected leads: what to consider?
Professor C. Starck (Berlin, DE)
Slides
Presentation thumbnail
Does the locking stylet limit my approach during lead extraction of noninfected leads?
Doctor B. Valente (Lisbon, PT)
Slides

Access the full session

Session thumbnail
Noninfected lead extraction indications: what should I consider!

The Event

Event poster

EHRA 2024

8 April 2024 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence and leading causes of transvenous lead extraction for nonfunctional leads in a real-world setting: a 5-year multicenter overview
13 April 2026
thumbnail
Webinar
Which patients benefit from leadless pacemakers?
25 January 2022
thumbnail
Congress Presentation
Percutaneous aspiration of infective endocarditis vegetations prior to transvenous lead extraction: a single-center experience
13 April 2026
thumbnail
Congress Presentation
Outcomes of entrapped right ventricular pacing or defibrillator leads following transcatheter tricuspid valve replacement
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources